Alfred Chung

2.2k total citations
90 papers, 1.7k citations indexed

About

Alfred Chung is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Alfred Chung has authored 90 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 29 papers in Oncology and 24 papers in Hematology. Recurrent topics in Alfred Chung's work include Multiple Myeloma Research and Treatments (22 papers), Protein Hydrolysis and Bioactive Peptides (13 papers) and Peptidase Inhibition and Analysis (12 papers). Alfred Chung is often cited by papers focused on Multiple Myeloma Research and Treatments (22 papers), Protein Hydrolysis and Bioactive Peptides (13 papers) and Peptidase Inhibition and Analysis (12 papers). Alfred Chung collaborates with scholars based in United States, Germany and Canada. Alfred Chung's co-authors include James W. Ryan, Una Ryan, Frederic E. Dorer, D. R. Schultz, Ravindra Kempaiah, Vivek Maheshwari, K. Sandy Pang, Larry C. Martin, A. Castro and Albert Castro and has published in prestigious journals such as Journal of Clinical Oncology, Blood and ACS Nano.

In The Last Decade

Alfred Chung

86 papers receiving 1.6k citations

Peers

Countries citing papers authored by Alfred Chung

Since Specialization

Citations

This map shows the geographic impact of Alfred Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred Chung more than expected).

Fields of papers citing papers by Alfred Chung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred Chung. The network helps show where Alfred Chung may publish in the future.

Co-authorship network of co-authors of Alfred Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred Chung. A scholar is included among the top collaborators of Alfred Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred Chung. Alfred Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AQUILA: Dousing the Embers of Smoldering Multiple Myeloma With Daratumumab Monotherapy 2025 ·The Hematologist ·(unknown), (unknown), (unknown), Alfred Chung, Ajai Chari	0
2	Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma 2024 ·Blood Advances ·Kevin Reyes, Yen‐Chun Liu, Chiung‐Yu Huang, Rahul Banerjee, T. John Martin, Sandy W. Wong, Jeffrey L. Wolf, Shagun Arora, Nina Shah, Ajai Chari, Alfred Chung	15
3	Efficacy, safety, and determination of RP2D of ABBV-383, a BCMA bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM). 2024 ·Journal of Clinical Oncology ·(unknown), Peter M. Voorhees, Anita D’Souza, Alfred Chung, Sascha A. Tuchman, Hana Safah, (unknown), Katja Weisel, Raphael Teipel, Neha Korde, Ravi Vij, (unknown), (unknown), (unknown), (unknown), Aarif Ahsan, Xin Li, Ziyi Jin, Chetasi Talati, Shaji Kumar	8
4	BCMA-directed CART therapy in patients with multiple myeloma and CNS involvement. 2024 ·Journal of Clinical Oncology ·Mahmoud Gaballa, Omar Castañeda Puglianini, Adam D. Cohen, Dan T. Vogl, Alfred Chung, Christopher J. Ferreri, Peter M. Voorhees, Doris K. Hansen, Krina K. Patel	1
5	P-045 Idecabtagene Vicleucel (ide-cel) in Patients (pts) With Clinical High-Risk Early Relapse Multiple Myeloma (MM) Without Front-Line (1L) Autologous Stem Cell Transplantation (ASCT): KarMMA-2 Cohort 2B 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Xavier Leleu, Alfred Chung, Noopur Raje, Meera Mohan, Reuben Benjamin, Adam S. Sperling, Larry Anderson, Madhav V. Dhodapkar, Shambavi Richard, Anna Truppel-Hartmann, (unknown), Fan Wu, (unknown), Ethan Thompson, Devender Dhanda, (unknown), (unknown), Maria Chaudhry, Melissa Alsina	1
6	Daratumumab Plus Lenalidomide (D-R) Versus Lenalidomide (R) Alone As Maintenance Therapy in Newly Diagnosed Multiple Myeloma (NDMM) after Transplant: Analysis of the Phase 3 Auriga Study Among Clinically Relevant Subgroups 2024 ·Blood ·(unknown), Larry D. Anderson, Alfred Chung, Chakra P. Chaulagain, (unknown), Andrew J. Cowan, (unknown), Sarah M. Larson, Douglas W. Sborov, Kenneth H. Shain, Rebecca Silbermann, (unknown), Maria Krevvata, Huiling Pei, Sharmila Patel, (unknown), Annelore Cortoos, Robin Carson, Thomas S. Lin, Ashraf Badros	1
7	Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain Amyloidosis 2023 ·Current Problems in Cancer ·Vanessa E. Kennedy, (unknown), (unknown), Nina Shah, Shagun Arora, Jeffrey L. Wolf, Thomas G. Martin, Mandar A. Aras, Alfred Chung, Sandy W. Wong	4
8	Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma 2023 ·Transplantation and Cellular Therapy ·Kevin Reyes, Chiung‐Yu Huang, Mimi Lo, Shagun Arora, Alfred Chung, Sandy W. Wong, Jeffrey L. Wolf, Rebecca L. Olin, Thomas Martin, Nina Shah, Rahul Banerjee	26
9	Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma 2023 ·Journal of Oncology Pharmacy Practice ·(unknown), (unknown), (unknown), Mimi Lo, Rebecca Young, (unknown), Ila M. Saunders, Rahul Banerjee, Richard Young, (unknown), Alfred Chung, Aaron S. Rosenberg, Caitlin Costello, Jeffrey Fine, Machelle Wilson, Nimish Patel, (unknown)	1
10	P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA 2023 ·HemaSphere ·Katja Weisel, Anita D’Souza, David D. Hurd, Peter M. Voorhees, Raphael Teipel, Alfred Chung, Cesar Rodriguez, (unknown), Neha Korde, Hana Safah, Orlando F. Bueno, (unknown), (unknown), (unknown), Jeremy A. Ross, Shane Lee, Ziyi Jin, (unknown), Shaji Kumar, Ravi Vij	1
11	Therapy-related myeloid neoplasms after treatment for plasma-cell disorders 2019 ·Best Practice & Research Clinical Haematology ·Alfred Chung, Michaela Liedtke	11
12	A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia 2017 ·Cancer Genetics ·Alfred Chung, Yanli Hou, Robert S. Ohgami, (unknown), Dianna G. Fisk, Krishna M. Roskin, Xu Li, Linda Gojenola, Charles D. Bangs, Daniel A. Arber, Andrew Fire, Athena M. Cherry, James L. Zehnder, Jason Gotlib, Jason D. Merker	14
13	Reversible, Allosteric Small-Molecule Inhibitors of Regulator of G Protein Signaling Proteins 2010 ·Molecular Pharmacology ·Levi L. Blazer, David L. Roman, Alfred Chung, Martha J. Larsen, Benjamin Greedy, Stephen M. Husbands, Richard R. Neubig	70
14	Radiation-Induced Early Pulmonary Endothelial Ectoenzyme Dysfunction in Vivo: Effect of Indomethacin 1994 ·Toxicology and Applied Pharmacology ·(unknown), (unknown), Sandra E. Burch, James W. Ryan, Alfred Chung, John D. Catravas	10
15	N-Glycosylation of Forms of Angiotensin Converting Enzyme from Four Mammalian Species 1993 ·Biochemical and Biophysical Research Communications ·(unknown), James W. Ryan, (unknown), Alfred Chung, (unknown), Ronald L. Urry	26
16	A Radiochemical Assay for Aminopeptidase N 1993 ·Analytical Biochemistry ·James W. Ryan, Alfred Chung, (unknown), (unknown), (unknown), (unknown)	9
17	Purification and characterization of guinea pig serum aminoacylproline hydrolase (aminopeptidase P) 1992 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·James W. Ryan, (unknown), (unknown), Alfred Chung, (unknown)	20
18	A Rapid, Simple Synthesis and Purification of Abscisic Acid Glucose Ester 1986 ·PLANT PHYSIOLOGY ·Stephen M. Southwick, Alfred Chung, Thomas L. Davenport, James W. Ryan	11
19	Angiotensin-converting enzyme: I. New strategies for assay 1980 ·Environmental Health Perspectives ·James W. Ryan, Alfred Chung, Una Ryan	18
20	Mammalian inhibitors of angiotensin converting enzyme (kininase II). 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), Luis Cuadrado Martín, Alfred Chung, (unknown)	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact